Bal Pharma, Australian co venture

Our Bureau

Bengaluru, March 6

 

Melbourne-based Akaal Pharma has entered into joint venture with Bengaluru-based Bal Pharma.

As a part of this JV, the venture called AB VET, will be funded by Bal Pharma to develop Akaal Pharma's Intellectual Property (IP) in the veterinary field, the company said in a statement.

The first veterinary indication will be against Atopic Dermatitis in dogs, wherein Akaal's ABV-119 is used to treat them.

Published on March 06, 2018
TOPICS
Bal Pharma Ltd

Previous Story Kobe Steel CEO to quit on quality data fraud

Next Story PETA to release findings of its probe into 9 Jallikattu events

MORE FROM BUSINESSLINE


 Getting recommendations just for you...
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.